Table 2 Clinical–epidemiological characteristics of the population with CKD according to the PLR level
Characteristics | PLR | p value | |
|---|---|---|---|
High (n = 28) | Normal (n = 314) | ||
Age (years)* | 72.6 (14.1) | 78.8 (11.6) | < 0.01 |
Sex** | |||
Female | 8 (28.6) | 119 (37.9) | 0.33 |
Male | 20 (71.4) | 195 (62.1) | |
Hypertension** | 0.37 | ||
Yes | 16 (57.1) | 206 (65.6) | |
No | 12 (42.9) | 108 (34.4) | |
Diabetes** | 0.48 | ||
Yes | 10 (35.7) | 92 (29.3) | |
No | 28 (64.3) | 222 (70.7) | |
CKD stage** | |||
1–2 | 2 (7.2) | 20 (6.4) | 0.62 |
3a–3b | 26 (92.8) | 284 (90.4) | |
4–5 | 0 (0.0) | 10 (3.2) | |
Laboratory profile | |||
Serum creatinine (mg/dL)* | 1.4 (0.3) | 1.4 (0.5) | 0.94 |
eGFR (ml/min/1.73 m2)* | 49.0 (11.1) | 47.2 (10.5) | 0.40 |
Glucose (mg/dL)*** | 88.5 (77–112) | 90 (83–103) | 0.47 |
Total protein (g/dL)* | 7.1 (0.7) | 7.2 (0.6) | 0.15 |
Albumin (g/dL)* | 4.0 (0.5) | 4.1 (0.4) | 0.06 |
AST (U/L)*** | 19 (18–25) | 23 (19–28) | 0.02 |
ALT (U/L)*** | 16 (12–24) | 18 (13–24) | 0.47 |
Total bilirubin (mg/dL)*** | 0.5 (0.44–0.70) | 0.6 (0.45–0.79) | 0.46 |
Alkaline phosphatase (U/L)*** | 117 (91–146) | 100 (81.5–126) | 0.08 |
Globulin (g/dL)* | 3.1 (0.5) | 3.1 (0.8) | 0.73 |
Hemoglobin (g/dL)* | 11.2 (1.9) | 12.2 (1.6) | < 0.01 |
Neutrophils (K/uL)* | 4.53 (1.6) | 3.89 (1.5) | 0.03 |